impact factor, citescore
logo
 

Letter

 

Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry


1, 2, 3, 4, 5, 6, 7, 8, 9

 

  1. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. mann@revma.cz
  2. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  3. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  4. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  5. Institute of Biostatistics and Analyses, Ltd., spinoff company of Masaryk University, Brno, Czech Republic.
  6. Institute of Biostatistics and Analyses, Ltd., spinoff company of Masaryk University, Brno, Czech Republic.
  7. IIIrd Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
  8. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  9. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

and the ATTRA Registry

CER11633
2019 Vol.37, N°2
PI 0342, PF 0343
Letter

Free to view
(click on article PDF icon to read the article)

PMID: 30620295 [PubMed]

Received: 20/08/2018
Accepted : 09/10/2018
In Press: 04/01/2019
Published: 19/03/2019

Rheumatology Article